{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:58:47Z","timestamp":1772553527719,"version":"3.50.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Parkinson\u2019s disease affects 2% of the population aged over 65 years and is the second most common neurodegenerative disorder in the general population. The appearance of motor symptoms is associated with the degeneration of dopaminergic neurons in the nigrostriatal pathway. Clinically significant nonmotor symptoms are also important for severe disability with disease progression. Pharmacological treatment with levodopa, which involves dopamine restitution, results in a temporary improvement in motor symptoms. Among the mechanisms underlying the pathogenesis of the disease are exacerbated oxidative stress, mitochondrial dysfunction, and neuroinflammation. A phytochemical prospecting study showed that the aqueous extract of the leaves from <jats:italic>Swietenia macrophylla<\/jats:italic> (Melineaceae), known as mahogany, has polyphenols with antioxidant and anti-inflammatory capacity in a significantly higher percentage than leaf extracts from other Amazonian plants. Furthermore, the antioxidant and anti-inflammatory capacity of aqueous extract of mahogany leaf has already been demonstrated in an <jats:italic>in vitro<\/jats:italic> model. In this study, we hypothesized that the aqueous extract of mahogany leaf (AEML) has a neuroprotective effect in a murine model of Parkinson\u2019s disease induced by 6-hydroxidopamine (6-OHDA), due to antioxidant and anti-inflammatory properties of its phenolic compounds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mice were treated daily with the mahogany extract at a dose of 50 mg\/kg, starting 7 days before 6-OHDA infusion until post-surgery day 7.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>The animals from the 6-OHDA\/mahogany group, which corresponds to animals injected with the toxin and treated with aqueous extract of the mahogany leaf, presented distinct behavioral phenotypes after apomorphine challenge and were therefore subdivided into 2 groups, 6-OHDA\/mahogany F1 and 6-OHDA\/mahogany F2. The F1 group showed a significant increase in contralateral rotations, whereas the F2 group did not show rotations after the apomorphine stimulus. In the F1 group, there was an increase, although not significant, in motor performance in the open field and elevated plus maze tests, whereas in the F2 group, there was significant improvement, which may be related to the lesser degree of injury to the nigrostriatal dopaminergic pathway. The TH+ histopathological analysis, a dopaminergic neuron marker, confirmed that the lesion to the nigrostriatal dopaminergic pathway was more pronounced in 6-OHDA\/mahogany F1 than in 6-OHDA\/mahogany F2. Our main result consisted of signs of improvement in the inflammatory profile in both the F1 and F2 6-OHDA\/mahogany groups, such as a lower number of IBA-1+ microglial cells in the ventral striatum and substantia nigra pars compacta and a reduction in GFAP+ expression, an astrocyte marker, in the dorsal striatum. In this study, several bioactive compounds in the aqueous extract of mahogany leaf may have contributed to the observed beneficial effects. Further studies are necessary to better characterize their applicability for treating chronic degenerative diseases with inflammatory and oxidative bases, such as Parkinson\u2019s disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2024.1351718","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:26:15Z","timestamp":1708489575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Aqueous extract of Swietenia macrophylla leaf exerts an anti-inflammatory effect in a murine model of Parkinson\u2019s disease induced by 6-OHDA"],"prefix":"10.3389","volume":"18","author":[{"given":"V\u00e1ldina Solimar Lopes","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson","family":"Valente-Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan Fidel Martins","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarina Loius Silva","family":"Meira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia Silva","family":"de Meira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton Nascimento","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o de Jesus Viana","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilmara de Nazareth Tavares","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Soares","family":"Fel\u00edcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Sumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-181525","article-title":"The amphetamine induced rotation test: a re-assessment of its use as a tool to monitor motor impairment and functional recovery in rodent models of Parkinson\u2019s disease","volume":"9","author":"Bj\u00f6rklund","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson\u2019s disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2006.12.016","article-title":"Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat","volume":"205","author":"Breit","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0104-6","article-title":"Potential of animal models for advancing the understanding and treatment of pain in Parkinson\u2019s disease","volume":"6","author":"Buhidma","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neubiorev.2005.04.017","article-title":"Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on","volume":"29","author":"Carobrez","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biom9070271","article-title":"Role of dietary supplements in the Management of Parkinson\u2019s disease","volume":"9","author":"Ciulla","year":"2019","journal-title":"Biomol. Ther."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnana.2018.00113","article-title":"Advances in Parkinson\u2019s disease: 200 years later","volume":"12","author":"Del Rey","year":"2018","journal-title":"Front. Neuroanat."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mds.25937","article-title":"The clinical spectrum of anxiety in Parkinson\u2019s disease","volume":"29","author":"Dissanayaka","year":"2014","journal-title":"Mov. Disord."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.12998\/wjcc.v11.i15.3385","article-title":"Astrocytes in the central nervous system and their functions in health and disease: a review","volume":"11","author":"Gradisnik","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology \u2014 reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"J. Microsc."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2011.06.021","article-title":"Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum","volume":"500","author":"Haleagrahara","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2011.11.027","article-title":"Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites","volume":"228","author":"Heuer","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s13311-020-00964-w","article-title":"Approaches to disease modification for Parkinson\u2019s disease: clinical trials and lessons learned","volume":"17","author":"Hung","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"606927","DOI":"10.3389\/fnagi.2020.606927","article-title":"Protective effect of the \u03b17 nicotinic receptor agonist PNU-282987 on dopaminergic neurons against 6-hydroxydopamine, regulating anti-neuroinflammatory and the immune balance pathways in rat","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/143547","article-title":"Neurobiology of depression and anxiety in Parkinson\u2019s disease","volume":"2011","author":"Kano","year":"2011","journal-title":"Parkinsons Dis."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","article-title":"Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson\u2019s disease","volume":"1328","author":"Khan","year":"2010","journal-title":"Brain Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.biopha.2020.110776","article-title":"Anxiety: an ignored aspect of Parkinson\u2019s disease lacking attention","volume":"131","author":"Khatri","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jnutbio.2015.10.013","article-title":"Naringin treatment induces neuroprotective effects in a mouse model of Parkinson\u2019s disease in vivo, but not enough to restore the lesioned dopaminergic system","volume":"28","author":"Kim","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7861\/clinmed.2020-0220","article-title":"Update on the diagnosis and management of Parkinson\u2019s disease","volume":"20","author":"Kobylecki","year":"2020","journal-title":"Clin. Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/nu10050642","article-title":"Polyphenols in Parkinson\u2019s disease: a systematic review of in vivo studies","volume":"10","author":"Kujawska","year":"2018","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s12035-017-0529-z","article-title":"Prolonged dysfunction of astrocytes and activation of microglia accelerate degeneration of dopaminergic neurons in the rat substantia nigra and block compensation of early motor dysfunction induced by 6-OHDA","volume":"55","author":"Kuter","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fnbeh.2020.00145","article-title":"To approach or avoid: an introductory overview of the study of anxiety using rodent assays","volume":"14","author":"La-Vu","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100136","DOI":"10.1016\/j.lana.2021.100136","article-title":"Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: a community based study","volume":"7","author":"Llibre-Guerra","year":"2022","journal-title":"The Lancet Regional Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.11.026","article-title":"Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2\/ARE signaling pathway","volume":"79","author":"Lou","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/WNR.0b013e32821c51fe","article-title":"Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats","volume":"18","author":"Ma","year":"2007","journal-title":"Neuroreport"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"666737","DOI":"10.3389\/fneur.2021.666737","article-title":"The pathogenesis of Parkinson\u2019s disease: a complex interplay between astrocytes, microglia, and T lymphocytes?","volume":"12","author":"MacMahon Copas","year":"2021","journal-title":"Front. Neurol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/glia.20990","article-title":"The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction","volume":"58","author":"Mathiisen","year":"2010","journal-title":"Glia"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"10465","DOI":"10.3390\/molecules180910465","article-title":"Biological activities and phytochemicals of Swietenia macrophylla","volume":"18","author":"Moghadamtousi","year":"2013","journal-title":"Molecules"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-011-9295-2","article-title":"Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson\u2019s disease","volume":"22","author":"Moshahid Khan","year":"2012","journal-title":"Neurotox. Res."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-022-00284-0","article-title":"Change in the incidence of Parkinson\u2019s disease in a large UK primary care database","volume":"8","author":"Okunoye","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18777","DOI":"10.3390\/molecules201018777","article-title":"In vitro cytoprotective effects and antioxidant capacity of phenolic compounds from the leaves of Swietenia macrophylla","volume":"20","author":"Pamplona","year":"2015","journal-title":"Molecules"},{"key":"ref41","volume-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2004"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/antiox9101007","article-title":"Behavioral tests in neurotoxin-induced animal models of Parkinson\u2019s disease","volume":"9","author":"Prasad","year":"2020","journal-title":"Antioxidants"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e52434","DOI":"10.3791\/52434","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.foodchem.2006.02.055","article-title":"Antioxidant activities and polyphenolic contents of fifteen selected plant species from the amazonian region","volume":"101","author":"Silva","year":"2007","journal-title":"Food Chem."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/antiox9080669","article-title":"Interaction of polyphenols as antioxidant and anti-inflammatory compounds in brain\u2013liver\u2013gut Axis","volume":"9","author":"Singh","year":"2020","journal-title":"Antioxidants"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fneur.2018.00170","article-title":"Non-motor symptoms of Parkinson\u2019s disease and their impact on quality of life in a cohort of Moroccan patients","volume":"9","author":"Tibar","year":"2018","journal-title":"Front. Neurol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2011.02.025","article-title":"Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats","volume":"304","author":"Wang","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuroscience.2015.05.068","article-title":"Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice","volume":"301","author":"Willard","year":"2015","journal-title":"Neuroscience"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic. Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1351718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T04:26:19Z","timestamp":1708489579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1351718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":53,"alternative-id":["10.3389\/fnins.2024.1351718"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1351718","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"article-number":"1351718"}}